Skip to content
Open access

Circulating Homocysteine and Choroid Plexus Volume Across the Alzheimer’s Disease Continuum: Cross-Sectional and Progression-Related Associations

Aug 2026 · Biology · Vol 15, pp. 1423 · 0 citations · 55 references
Medicine

TL;DR

Exploratory reanalysis of independent postmortem single-nucleus and spatial transcriptomic datasets identified choroid plexus epithelial expression states involving one-carbon metabolism-related genes and spatial organization near vascular compartments that provide tissue-level biological context for the associations observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Abstract

Simple Summary Alzheimer’s disease progression involves complex changes in both the brain and the body, but the biological links between peripheral metabolic alterations and brain structural changes remain unclear. This study examined whether elevated blood homocysteine levels were associated with larger choroid plexus volume, an MRI-derived measure of the choroid plexus, a structure involved in maintaining the brain environment. In a large cohort covering normal cognition, mild cognitive impairment, and Alzheimer’s disease dementia, higher blood homocysteine levels were associated with increased choroid plexus volume, and larger choroid plexus volume was associated with a higher risk of progression from mild cognitive impairment to Alzheimer’s disease dementia. Exploratory reanalysis of independent postmortem single-nucleus and spatial transcriptomic datasets identified choroid plexus epithelial expression states involving one-carbon metabolism-related genes and spatial organization near vascular compartments. These independent transcriptomic findings provide tissue-level biological context for the associations observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and support further validation of these epithelial expression states.

Read PDF

Similar papers

Open access Sep 2026

Regional choroid plexus calcifications and their associations with aging, brain structure, and disease

QSM-derived CPcal is a scalable, radiation-free imaging phenotype that complements volumetry by characterizing calcific CP tissue, which is associated with cardiometabolic health, brain aging, and neurodegenerative risk, particularly in the third ventricle.

Iyad Ba Gari, Alyssa H. Zhu, Ravi R. Bhatt et al. · 0 citations
Sep 2026

Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.

OBJECTIVE Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD), with significant pathological overlap between the two conditions. However, the impact of Alzheimer's co-pathology on basal forebrain (BF) atrophy and its relationship with neurodegeneration and...

Daniele Urso, Thomas Giannelli, B. Tafuri et al. · 0 citations
Sep 2026

MRI-derived choroid plexus volume and longitudinal cognitive decline in Parkinson's disease.

BACKGROUND Magnetic resonance imaging (MRI)-derived choroid plexus (CP) volume has been associated with cognition in Parkinson's disease, but its close relationship with ventricular anatomy complicates interpretation. METHODS We analyzed Parkinson's Progression Markers Initiative (PPMI) data. Baseline FreeSurfer-deri...

Qian-Kun Lv, Zi-Qiu Zhou, Ling-Ying Shi et al. · 0 citations
Open access Jul 2026

Hippocampal mediation in the lipid–Alzheimer's disease pathway: A high‐dimensional mediation analysis stratified by APOE and sex

The left hippocampus is a critical mediator linking specific plasma lipids to AD progression, with an additional vascular pathway via white matter hyperintensities emerging after comorbidity adjustment, supporting a dual neurodegenerative–vascular pathway.

Yun-Jia Cao, Yu-Wei Fan, Qing-Tao Meng et al. · 0 citations
Open access Sep 2026

Gray matter atrophy mediates the association between cerebral hypometabolism and cognitive impairment in Alzheimer’s disease

Objective Alzheimer’s disease (AD) is characterized by amyloid deposition, brain hypometabolism, gray matter atrophy and cognitive decline, yet their causal interactions are poorly defined. This multimodal PET/MRI study explored regional gray matter volume (GMV) loss and glucose hypometabolism in AD patients, and clari...

Shi-Qi Zhao, Jian-Wen Chen, Pei-Xue Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.